Journals / Turkish journal of physical medicine and rehabilitation / 2021 / Cilt: 67 - Sayı: 1

Pharmacological and non-pharmacological treatment approaches to chronic lumbar back pain

Pages
1–10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we discuss pharmacological and non-pharmacological treatment approaches for chronic low back pain in the light of current data and guidelines

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Low back pain is a common and important cause of disability.
📊
Key Findings & Data:Chronic pain increases disability and cost.
💡
Conclusion & Impact:In this review, we discuss pharmacological and non-pharmacological treatment approaches for chronic low back pain in the light of current data and guidelines
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Low back pain is a common and important cause of disability. Chronic pain increases disability and cost. In this review, we discuss pharmacological and non-pharmacological treatment approaches for chronic low back pain in the light of current data and guidelines

🔖

Cite This Article

KETENCİ, A., ZURE, M. (2021). Pharmacological and non-pharmacological treatment approaches to chronic lumbar back pain. Turkish journal of physical medicine and rehabilitation, Cilt: 67 - Sayı: 1, 1–10. https://ajindex.com/articles/403023

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet 2018;391:2356-67 2. Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet 2018;391:2368-83. 3. Oliveira CB, Maher CG, Pinto RZ, Traeger AC, Lin CC, Chenot JF, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J 2018;27:2791-803. 4. Fornari M, Robertson SC, Pereira P, Zileli M, Anania CD, Ferreira A, et al. Conservative treatment and percutaneous pain relief techniques in patients with lumbar spinal stenosis: WFNS spine committee recommendations. World Neurosurg X 2020;7:100079. 5. Kreiner DS, Hwang SW, Easa JE, Resnick DK, Baisden JL, Bess S, et al. An evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy. Spine J 2014;14:180-91. 6. Parr A, Askin G. Non-radicular low back pain: Assessment and evidence-based treatment. Aust J Gen Pract 2020;49:724-7. 7. Kreiner DS, Matz P, Bono CM, Cho CH, Easa JE, Ghiselli G, et al. Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of low back pain. Spine J 2020;20:998-1024. 8. Suman A, Armijo-Olivo S, Deshpande S, Marietta-Vasquez J, Dennett L, Miciak M, et al. A systematic review of the effectiveness of mass media campaigns for the management of low back pain. Disabil Rehabil 2020:1-29. 9. Saragiotto BT, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG. Paracetamol for low back pain. Cochrane Database Syst Rev 2016;2016:CD012230. 10. Chou R, Deyo R, Friedly J, Skelly A, Weimer M, Fu R, et al. Systemic pharmacologic therapies for low back pain: A systematic review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2017;166:480-92. 11. Bhatia A, Engle A, Cohen SP. Current and future pharmacological agents for the treatment of back pain. Expert Opin Pharmacother 2020;21:857-61. 12. Rasmussen-Barr E, Held U, Grooten WJ, Roelofs PD, Koes BW, van Tulder MW, et al. Non-steroidal anti- inflammatory drugs for sciatica. Cochrane Database Syst Rev 2016;10:CD012382. 13. Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ. Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. Eur J Pain 2017;21:228-37. 14. Sha